• Magazine
    • Current Issue
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar and Deadlines
    • Dynamic Chiropractic
      • Newspaper
      • Subscription
    • The American Chiropractor
      • Magazine
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • Ebooks
    • Ecourses
    • Sponsored Content
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Podcast
  • Content Hubs
  • Products & Services
    • View Products & Services Directory
    • Browse Buyers Guide
    • Submit a Product
    • Vendor Login
  • Datebook
    • View Events
    • Post an Event
    • Become an Events Poster
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us

Your Online Practice Partner

Chiropractic Economics
Your Online Practice Partner
Advertise Subscribe
  • Home
  • News
  • Webinars
  • Chiropractic Research
  • Students/New DCs

CBD public hearing announced by U.S. Food and Drug Administration

Rick Vach April 3, 2019

CBD oils and products will be under the spotlight when the U.S. Food and Drug Administration (FDA) holds its first public hearing on legalizing CBD in food and drinks on May 31, according to CNBC.

The FDA is specifically looking toward regulating manufacturing, marketing and labeling.

“It’s critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDA’s regulatory oversight of these products — especially as the agency considers whether it could be appropriate to exercise its authority to allow the use of CBD in dietary supplements and other foods,” outgoing FDA Commissioner Scott Gottlieb said in a statement Tuesday.

CBD or cannabidiol is a non-psychoactive compound found in hemp that relieves pain and other maladies without altering the mind like THC. In December 2018 the U.S. Congress legalized CBD derived from hemp in the Farm Bill.

CBD stores are popping up in towns across the U.S., and large drug store chains such as Walgreens and CVS have announced plans to sell non-food and non-drink CBD products.

“This is a complicated topic and we expect that it could take some time to resolve fully,” Gottlieb said. “Nevertheless, we’re deeply focused on this issue and committed to continuing to engage relevant stakeholders as we consider potential paths forward.”

The FDA has already been proactive along with the Federal Trade Commission on clamping down on companies making outrageous CBD claims, issuing warning letters to three companies for unproven allegations, including treating cancer and Alzheimer’s disease.

“The FDA continues to be concerned about the proliferation of egregious medical claims being made about products asserting to contain CBD that haven’t been approved by the FDA, such as the products and companies receiving warning letters today,” Gottlieb said.

Consumers have been flocking to the product, but consumer education lags behind on what some are terming a “miracle drug.” CBD potency in products can vary greatly depending if they are derived from full-spectrum hemp oil, broad-spectrum hemp oil or CBD isolate.

For more info on CBD go to chiroeco.com/?s=cbd.

Related Posts

  • Registration open for annual PFCS educational seminarRegistration open for annual PFCS educational seminar
  • TCC welcomes new provostTCC welcomes new provost
  • Chiropractic patients: 4 in 5 consumers now using essential daily supplementsChiropractic patients: 4 in 5 consumers now using essential daily supplements
  • Council on Chiropractic Education proposes revisions to accreditation standardsCouncil on Chiropractic Education proposes revisions to accreditation standards
  • Weave Communications acquires TrueLark, AI integrationWeave Communications acquires TrueLark, AI integration

Filed Under: Industry News

Current Issue

Issue 16 cover

Get Exclusive Content! Join our email list

Follow Us

  • Facebook
  • X (Twitter)
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

Compare Subscriptions

Dynamic Chiropractic

The American Chiropractor

8430 Enterprise Circle, Suite 200

Lakewood Ranch, FL 34202

Phone 800-671-9966

CONTACT US »

Privacy Policy | Terms of Service

Copyright © Chiropractic Economics, A Gallagher Company. All Rights Reserved.

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just fill out our form to request your FREE subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Proud Sponsor of the Foundation for Chiropractic Progress
Issue 17 cover